# FDA Inspection 1230047 - Nosipho P. Ngubane, M.D. - February 02, 2024

Source: https://www.keypedia.com/records/fda_inspections/nosipho-p-ngubane-md/a5934dc8-61f5-4f96-bf2c-f8f47f2d96c6
Source feed: FDA_Inspections

> FDA Inspection 1230047 for Nosipho P. Ngubane, M.D. on February 02, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230047
- Company Name: Nosipho P. Ngubane, M.D.
- Inspection Date: 2024-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1086852 - 2019-03-28](https://www.keypedia.com/records/fda_inspections/nosipho-p-ngubane-md/ec9018a3-2656-4348-8465-ed2bb4deea2d)

Company: https://www.keypedia.com/companies/nosipho-p-ngubane-md/26dc1581-c50a-4867-b2e3-6955a36e5642

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c